For forty-four years, the San Antonio Breast Cancer Symposium’s mission has been to provide state-of-the-art information on breast cancer research. The University of Kansas Cancer Center Post San Antonio Review will be a condensed review of the SABCS meeting held in December and will give healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care.  

This meeting will facilitate the exchange and discussion of the new data in the context with what is being done now in a virtual format. The target audience are physicians, advanced practitioners, pharmacists, nurses, fellows, and other healthcare professionals involved in breast cancer prevention, treatment, and survivorship. 

2022 KU Post San Antonio Review Website Agenda.png

Accreditation Information | 4.00

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferencing. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Amedco LLC designates this activity for a maximum of 4.00 ANCC contact hours.


Amedco LLC designates this activity for a maximum of 4.00 knowledge-based CPE contact hours.

American Board of Internal Medicine (ABIM) MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.

Learning Objectives

  • Determine best application of new targeted therapies in patients with early-stage and metastatic disease  

  • Discuss the advances in systemic therapy likely to change current practices for treatment of breast cancer  

  • Know how to utilize genomic tools for systemic therapy decision making and prediction of treatment response.  

  • Be familiar with germ-line genetic testing options for hereditary breast cancer, including advantages and disadvantages of extended panel testing  

  • Evaluate local therapy options for operable breast cancer depending on stage, and the use of neoadjuvant therapy  

  • Identify evidence-based recommendations for decreasing symptoms and improving quantity and/or quality of life in survivors 

  • Free registration and access to a user-friendly virtual platform with live tech support 

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies 

  • Enduring video content for watching at your leisure 

  • Nation-wide networking with peers, colleagues, and medical professionals  

  • Real-time collaboration with polls, Q&A, live chats, and private messaging 

  • Access to the latest industry information and resources  

  • Giveaways and digital gift cards when you participate 

What to Expect

Past Conference Content


Become an Exhibitor 

Follow for Updates